Funded Tech Companies
Vedere Bio II
Vedere Bio II is a biopharmaceutical venture, based in Cambridge. Financial backing came from Octagon Investments Fund, Atlas Venture and Mission BioCapital.
Company Overview
Company Name
Vedere Bio II
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Vedere Bio II is pioneering beyond traditional gene therapy to not just slow vision loss from inherited retinal degenerations (IRDs) or dry age-related macular degeneration (dry AMD) with geographic atrophy (GA), but actually restore it.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/19/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cyrus Mozayeni
Chief Operating Officer
Mark Gaffney
Company Investors
- Octagon Investments Fund
- Atlas Venture
- Mission BioCapital
- Samsara BioCapital
- Casdin Capital
- Retinal Degeneration
Browse more funded tech companies:
Vedantra Pharmaceuticals | Vedero Software
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs